Literature DB >> 3497092

Autoantibodies to purified nuclear proteins related to DNA metabolism during ageing and in SLE patients.

G C Astaldi Ricotti, M Pazzaglia, A M Martelli, A Cerino, M Bestagno, A Caprelli, S Riva, M A Pedrini, A Facchini.   

Abstract

In this study the specificity of circulating autoantibodies in ANA+ aged donors, ANA- donors and SLE patients was investigated by immunoblotting on total nuclear proteins and by ELISA on purified nuclear proteins, possibly related to DNA metabolism, such as DNA polymerase alpha, DNA-dependent ATPase, DNA Topoisomerase I, ssDBP, hnRNP, HMG and histones. Immunoblotting showed that sera from ANA+ aged donors present fewer antibodies to nuclear proteins, especially to those between 21,000 and 45,000, molecular weight (MW), than sera from SLE patients. When the specificity of antisera was further studied on purified nuclear proteins, it was found that the majority of sera from SLE patients react with most of the proteins tested, whereas sera from ANA+ aged donors mainly react with DNA polymerase alpha, DNA-dependent ATPase, DNA Topoisomerase I and histones. In addition, sera from a few ANA- donors also reacted with certain purified nuclear proteins in a statistically significant age-related manner.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497092      PMCID: PMC1453402     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins.

Authors:  G H Goodwin; E W Johns
Journal:  Methods Cell Biol       Date:  1977       Impact factor: 1.441

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Transcription of ribonucleic acid in isolated mouse myeloma nuclei.

Authors:  W F Marzluff; E C Murphy; R C Huang
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Age influence on the immune system.

Authors:  T Makinodan; M M Kay
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

Review 6.  Current perspectives on serological reactions in SLE patients.

Authors:  M Reichlin
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

7.  Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Authors:  G C Sharp; W S Irvin; C M May; H R Holman; F C McDuffie; E V Hess; F R Schmid
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

8.  Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases.

Authors:  M Bustin; J Reisch; L Einck; J H Klippel
Journal:  Science       Date:  1982-03-05       Impact factor: 47.728

9.  Mammalian single-stranded DNA binding protein UP I is derived from the hnRNP core protein A1.

Authors:  S Riva; C Morandi; P Tsoulfas; M Pandolfo; G Biamonti; B Merrill; K R Williams; G Multhaup; K Beyreuther; H Werr
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

10.  Total purification of a DNA-dependent ATPase and of a DNA-binding protein from human cells.

Authors:  G Biamonti; F Cobianchi; A Falaschi; S Riva
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  3 in total

1.  Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.

Authors:  Sanjeev Kumar; Karen A Bunting; Jatinderpal Kalsi; John A Hinks; David S Latchman; Laurence H Pearl; David A Isenberg
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

2.  Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.

Authors:  R Meliconi; M Bestagno; C Sturani; C Negri; V Galavotti; C Sala; A Facchini; G Ciarrocchi; G Gasbarrini; G C Astaldi Ricotti
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  Antibodies to topoisomerase II in idiopathic pulmonary fibrosis.

Authors:  R Meliconi; C Negri; R M Borzì; A Facchini; C Sturani; L Fasano; M Fabbri; G C Astaldi Ricotti
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.